Lorem ipsum dolor sit amet In optio atque rem, quis similique ducimus hic cum eum
Lorem, ipsum dolor sit amet consectetur adipisicing elit. In optio atque rem, quis similique ducimus hic cum eum fugiat beatae dignissimos magni nihil libero blanditiis sapiente sint deleniti at illum!
One-size does not fit all across today's diverse and dynamic test settings. From antigen to molecular tests and various use cases, rapid test methods offer unique and overlapping utility, advantages, and disadvantages.
Expert perspectives on rapid point-of-care testing for respiratory infections
Following 19 months of consultation, this report sets out the Review on Antimicrobial Resistance’s final recommendations to tackle antimicrobial resistance (AMR) globally, as commissioned by sponsors, the UK Government and the Wellcome Trust.
Tackling drug-resistant infections globally: report and recommendations
This updated guidance from the Infectious Diseases Society of America (IDSA) covers diagnosis,
treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenza.
IDSA clinical practice guideline update on the management of seasonal influenza
Join this interactive discussion on how the different adoption of C-reactive protein point-of-care testing in different countries has influenced and could influence antibiotic misuse and antimicrobial resistance rates.
Fighting forwards: how to keep antibiotics working in an age of resistance
In our feature article series, we take a look at publications of particular relevance to point-of-care testing (POCT), providing summaries and expert commentary on the key aspects of the paper and within the wider context of POCT systems.In this article, we cover the below publication by Professor Cooke and co-authors
Respiratory tract infections in primary care: narrative review of CRP point-of-care testing and antibacterial use
The views and opinions presented are of the author only. The content contained in this podcast is intended for informational / educational purposes only.
Point-of-care testing for reducing risk and improving management of infectious diseases
The 31st European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) will bring together more than 14,000 attendees from all over the world, plus experts from relevant fields to present the latest findings and share their expertise.
European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
Health Information and Quality Authority (HIQA), published online April 2019This health technology assessment (HTA) aimed to establish the clinical and cost-effectiveness of CRP POCT, plus examined the organisational implications of the potential introduction of the technology into primary care. A summary of key findings is provided below:
Health Technology Assessment of CRP POCT to guide antibiotic prescribing for acute respiratory tract infections in primary care settings
en
今すぐアクセス
認定コンテンツ
限定
By using this site, you agree with our use of cookies.
